Public Services and Procurement Minister Anita Anand said today that global pharmaceutical giant Pfizer will temporarily reduce shipments of its vaccine to Canada, further complicating the slow rollout of inoculations.
Anand said she was told last night that Pfizer will send fewer doses than expected because it is pausing some production lines at its facility in Puurs, Belgium, in order to expand long-term manufacturing capacity.
“This expansion work means that Pfizer is temporarily reducing deliveries to all countries receiving vaccines manufactured at its European facility, and that includes Canada,” Anand told reporters at a public health briefing.
“Pfizer believes that by the end of March it will be able to catch up, such that we will be on track for the total committed doses for Q1,” she said, referring to the first quarter of the calendar year.
Anand stressed that this is a “temporary reduction” and not a “stoppage,” as some doses will still be shipped to Canada in this period when some Pfizer lines are idled.
“It’s going to be temporary, it’s not a loss, and we will make up those doses,” she said, adding deliveries will be disrupted for “two or three weeks.”
WATCH | Canada affected by Pfizer vaccine production delay in Europe:
Maj.-Gen. Dany Fortin, the military commander leading vaccine logistics, said Thursday that Canada was expecting deliveries of 208,000 doses of the Pfizer product each week for the rest of January. He also projected that 1.4 million doses would be delivered in February.
Anand said those delivery numbers will change as a result of this manufacturing hiccup, but she couldn’t say by how much.
“I am aware this morning that Pfizer is speaking with the Public Health Agency of Canada to provide further information related to the numbers so planning can take place,” she said.
Anand said the federal government still expects to receive roughly four million doses of the Pfizer product in the first three months of this year. Moderna is expected to deliver another two million doses of its vaccine.
Pfizer also has a plant in Kalamazoo, Mich., but all of Canada’s doses are being shipped from the company’s European operation.